Ingrid A. Stock

Discovery of a human liver glycogen phosphorylase inhibitor that lowers blood glucose <i>in vivo</i>

William H. Martin, Dennis J. Hoover, Sandra J. Armento et al. · Proceedings of the National Academy of Sciences · 1998 · 230 citations · Full text

Glycobiology, Metabolic Remodeling, Experimental Pharmacology +17

Efficient Liver Targeting by Polyvalent Display of a Compact Ligand for the Asialoglycoprotein Receptor

Carlos Sanhueza, Michael M. Baksh, Benjamin A. Thuma et al. · Journal of the American Chemical Society · 2017 · 108 citations · Full text

Drug Target, Medicinal Chemistry, Asialoglycoprotein Receptor +19

Indole-2-carboxamide Inhibitors of Human Liver Glycogen Phosphorylase

Dennis J. Hoover, Sheri Lefkowitz-Snow, Jana L. Burgess-Henry et al. · Journal of Medicinal Chemistry · 1998 · 102 citations · Full text

Cardiovascular Pharmacology, Altmetric Attention Score, Pharmacotherapy +17

CP-481,715, a Potent and Selective CCR1 Antagonist with Potential Therapeutic Implications for Inflammatory Diseases

Ronald P. Gladue, Laurie Tylaska, William H. Brissette et al. · Journal of Biological Chemistry · 2003 · 89 citations · Full text

Design and Synthesis of Truncated EGF-A Peptides that Restore LDL-R Recycling in the Presence of PCSK9 In Vitro

Christina I. Schroeder, Joakim E. Swedberg, Jane M. Withka et al. · Chemistry & Biology · 2014 · 72 citations